Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

Share Price is delayed by 15 minutes
Get Live Data
55.90    0.90 (1.64%)
Bid:
55.60
Ask:
56.10
Spread: 0.50 (0.899%)
Market Cap: £738.24m
IQE Live PriceLast checked at - London Stock Exchange

Intraday IQE Share Chart

Form 8.3 IQE PLC

19 Mar 2026 11:10

RNS Number : 3423X
Barclays PLC
19 March 2026
Β 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Β 

Barclays PLC.

(b)

Owner or controller of interest and short

Β 

Β 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

IQE PLC

Β 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

Β 

Β 

offeror/offeree, state this and specify identity of

Β 

offeror/offeree:

(e)

Date position held/dealing undertaken:

18 Mar 2026

(f)

In addition to the company in 1(c) above, is the discloser making

NO

Β 

Β 

Β 

disclosures in respect of any other party to the offer?

Β 

Β 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

Β 

Β 

to which the disclosure relates following the dealing(if any)

Β 

Class of relevant security:

1p ordinary

Β 

Interests

Short Positions

Β 

Number

(%)

Number

(%)

(1)

Relevant securities owned

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

1,413,434

0.14%

8,778,305

0.90%

(2)

Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

8,778,305

0.90%

1,413,433

0.14%

(3)

Stock-settled derivatives (including options)

Β 

Β 

Β 

Β 

Β 

and agreements to purchase/sell:

Β 

Β 

0

0.00%

0

0.00%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

TOTAL:

Β 

Β 

10,191,739

1.04%

10,191,738

1.04%

(b)

Rights to subscribe for new securities (including directors and other executive

Β 

Β 

options)

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant security in relation to

Β 

Β 

Β 

Β 

which subscription right exists

Β 

Β 

Β 

Β 

Details, including nature of the rights

Β 

Β 

Β 

Β 

concerned and relevant percentages:

Β 

Β 

Β 

Β 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchases and sales

Β 

Β 

Β 

Β 

Β 

Class of relevant

Purchase/sale

Number of

Price per unit

security

Β 

securities

Β 

1p ordinary

Purchase

2,065,874

0.2594 GBP

1p ordinary

Purchase

1,116,050

0.2603 GBP

1p ordinary

Purchase

389,034

0.2553 GBP

1p ordinary

Purchase

232,392

0.2563 GBP

1p ordinary

Purchase

173,334

0.2555 GBP

1p ordinary

Purchase

170,937

0.2511 GBP

1p ordinary

Purchase

140,078

0.2577 GBP

1p ordinary

Purchase

115,130

0.2587 GBP

1p ordinary

Purchase

112,030

0.2479 GBP

1p ordinary

Purchase

109,216

0.2525 GBP

1p ordinary

Purchase

95,000

0.2544 GBP

1p ordinary

Purchase

75,483

0.2618 GBP

1p ordinary

Purchase

55,000

0.2576 GBP

1p ordinary

Purchase

38,434

0.2520 GBP

1p ordinary

Purchase

24,151

0.2543 GBP

1p ordinary

Purchase

11,648

0.2663 GBP

1p ordinary

Purchase

10,000

0.2337 GBP

1p ordinary

Purchase

1

0.2485 GBP

1p ordinary

Sale

1,067,781

0.2552 GBP

1p ordinary

Sale

805,970

0.2555 GBP

1p ordinary

Sale

181,615

0.2518 GBP

1p ordinary

Sale

115,000

0.2570 GBP

1p ordinary

Sale

52,959

0.2543 GBP

1p ordinary

Sale

49,747

0.2605 GBP

1p ordinary

Sale

43,217

0.2540 GBP

1p ordinary

Sale

29,545

0.2204 GBP

1p ordinary

Sale

27,991

0.2502 GBP

1p ordinary

Sale

23,506

0.2363 GBP

1p ordinary

Sale

17,519

0.2472 GBP

1p ordinary

Sale

17,299

0.2699 GBP

1p ordinary

Sale

15,000

0.2500 GBP

1p ordinary

Sale

13,268

0.2530 GBP

1p ordinary

Sale

10,000

0.2337 GBP

1p ordinary

Sale

8,437

0.2535 GBP

1p ordinary

Sale

123

0.2515 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(b)

Cash-settled derivative transactions

Β 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

Β 

reference

unit

security

Β 

Β 

securities

Β 

1p ordinary

SWAP

Increasing Long

4,700

0.2163 GBP

1p ordinary

SWAP

Increasing Long

29,545

0.2204 GBP

1p ordinary

SWAP

Increasing Long

123

0.2515 GBP

1p ordinary

SWAP

Increasing Long

67,413

0.2555 GBP

1p ordinary

SWAP

Decreasing Long

19,698

0.2160 GBP

1p ordinary

SWAP

Decreasing Long

1

0.2485 GBP

1p ordinary

SWAP

Decreasing Long

109,216

0.2525 GBP

1p ordinary

SWAP

Decreasing Long

122,943

0.2552 GBP

1p ordinary

SWAP

Decreasing Long

266,091

0.2553 GBP

1p ordinary

SWAP

Decreasing Long

31,188

0.2555 GBP

1p ordinary

SWAP

Decreasing Long

157,088

0.2577 GBP

1p ordinary

SWAP

Decreasing Long

1,099,040

0.2604 GBP

1p ordinary

SWAP

Decreasing Long

140,300

0.2620 GBP

1p ordinary

SWAP

Decreasing Long

11,648

0.2663 GBP

1p ordinary

CFD

Increasing Long

77,790

0.2554 GBP

1p ordinary

CFD

Increasing Long

672,873

0.2555 GBP

1p ordinary

CFD

Decreasing Long

209,807

0.2527 GBP

1p ordinary

CFD

Decreasing Long

133,515

0.2554 GBP

1p ordinary

CFD

Decreasing Long

998,093

0.2555 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(c)

Stock-settled derivative transactions (including options)

Β 

(i)

Writing, selling, purchasing or varying

Β 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

Β 

date

money

relevant

Β 

selling,

securities

per unit

Β 

Β 

paid/

security

Β 

varying etc

to which

Β 

Β 

Β 

received

Β 

Β 

Β 

option

Β 

Β 

Β 

per unit

Β 

Β 

Β 

relates

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii)

Exercise

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

Β 

Β 

securities

unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d)

Other dealings (including subscribing for new securities)

Β 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

Β 

Β 

applicable)

Β 

Β 

Β 

Β 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding,

Β 

Β 

formal or informal, relating to relevant securities which may be an inducement to deal

Β 

Β 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

Β 

to the offer or any person acting in concert with a party to the offer:

Β 

Β 

Β 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between

Β 

Β 

the person making the disclosure and any other person relating to:

Β 

Β 

(i) the voting rights of any relevant securities under any option; or

Β 

Β 

Β 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

Β 

Β 

any derivative is referenced:

Β 

Β 

Β 

Β 

Β 

Β 

NONE

(c)

Attachments

Β 

Β 

Β 

Β 

Β 

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

19 Mar 2026

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETGPURWWUPQGUB
Date   Source Headline
12th Jun 20177:00 amRNSCardiff hosts international VCSEL technology event
1st Jun 20177:00 amRNSIQE wins 2017 Raytheon Supplier Award
29th Nov 20168:04 amRNSIQE and BLUGLASS announce strategic partnership
17th May 20167:00 amRNSIQE news update from CS-Mantech conference
16th May 20167:00 amRNSIQE Joins imec's GaN-on-Si Program
19th Apr 20167:16 amRNSIQE joins EUR15m project
17th Feb 20167:05 amRNSProfessor Colin Whitehouse appointed as CSC Chair
8th Jan 20167:01 amRNSCompound Semiconductor Catapult Centre announced
7th Oct 20157:00 amRNSIQE's GaN on Si achieves breakthrough results
30th Jul 201511:00 amRNSIQE key partner in US Integrated Photonics program
21st Apr 20157:00 amRNSIncreasing demand for IQE's Infrared products
31st Mar 20147:00 amRNS200mm GaN on Silicon for next generation CMOS
19th Mar 20147:00 amRNSIQE delivers 150mm (6") VCSEL epiwafers
13th Mar 20147:00 amRNSIQE's VCSEL wafers enable record performance
11th Mar 20147:20 amRNSPresentation at OFC
22nd Aug 20137:00 amRNSIQE reports new CPV cell efficiency
5th Jun 20132:22 pmRNSMerger Update
8th Mar 20133:00 pmRNSMerger Update
8th Jan 20138:39 amRNSStatement regarding press articles
31st Jul 20123:54 pmRNSDirectorate Change
10th Apr 20125:11 pmRNSDirector Dealings
27th Mar 20122:00 pmRNSPartnership Agreement
8th Feb 20124:10 pmRNSCompletion of Placing
17th Feb 20103:56 pmRNSNominated Adviser Change of Name
7th Aug 20094:42 pmRNSHolding(s) in Company
7th Aug 20094:30 pmRNSBondholders meeting
7th Aug 20093:51 pmRNSDirector Dealing in Shares
12th Jun 20081:42 pmRNSAdditional Listing
15th Apr 20087:01 amRNSAdditional Listing
7th Apr 200812:14 pmRNSDirector/PDMR Shareholding
28th Mar 200811:52 amRNSDirector/PDMR Shareholding
19th Mar 20087:00 amRNSDirector/PDMR Shareholding
17th Mar 20081:00 pmRNSContract Win
17th Mar 20087:01 amRNSFinal Results
28th Feb 20083:27 pmRNSHolding(s) in Company
19th Feb 20088:30 amRNSNotice of Results
25th Jan 20087:00 amRNSBank Facilities
17th Jan 20087:00 amRNSTrading Update
16th Jan 200811:15 amRNSBroker Appointment
15th Jan 200812:12 pmRNSDirector/PDMR Shareholding
9th Jan 20084:26 pmRNSAdditional Listing
7th Jan 20087:00 amRNSDirector/PDMR Shareholding
4th Jan 200812:46 pmRNSHolding(s) in Company
19th Dec 20077:30 amRNSAdditional Listing
18th Dec 20073:52 pmRNSSubstrate supply contract
13th Dec 20077:01 amRNSSuccessful Qualifications
9th Nov 200710:53 amRNSDirector/PDMR Shareholding
3rd Oct 200710:41 amRNSDirector/PDMR Shareholding
1st Oct 20072:44 pmRNSAdditional Listing
28th Sep 200710:14 amRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.